FDA: Certain Epinephrine Autoinjector Devices May Have Missing Safety Component

First Study Investigating Antibody Treatment for COVID-19 Begins

New Oral Treatment for Relapsing Forms of MS Now Available

Cyramza Plus Erlotinib Approved for First-Line Metastatic NSCLC With EGFR Mutations

Cefiderocol Gets Priority Review for Nosocomial Pneumonia